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Purpose:We investigated if oral ingestion of ibuprofen influenced leucocyte recruitment
and infiltration following an acute bout of traditional resistance exercise.
Methods: Sixteen male subjects were divided into two groups that received the
maximum over-the-counter dose of ibuprofen (1200mg d−1) or a similarly administered
placebo following lower body resistance exercise. Muscle biopsies were taken from
m.vastus lateralis and blood serum samples were obtained before and immediately after
exercise, and at 3 and 24 h after exercise. Muscle cross-sections were stained with
antibodies against neutrophils (CD66b and MPO) and macrophages (CD68). Muscle
damage was assessed via creatine kinase and myoglobin in blood serum samples, and
muscle soreness was rated on a ten-point pain scale.
Results: The resistance exercise protocol stimulated a significant increase in the number
of CD66b+ and MPO+ cells when measured 3 h post exercise. Serum creatine kinase,
myoglobin and subjective muscle soreness all increased post-exercise. Muscle leucocyte
infiltration, creatine kinase, myoglobin and subjective muscle soreness were unaffected
by ibuprofen treatment when compared to placebo. There was also no association
between increases in inflammatory leucocytes and any other marker of cellular muscle
damage.
Conclusion: Ibuprofen administration had no effect on the accumulation of neutrophils,
markers of muscle damage or muscle soreness during the first 24 h of post-exercise
muscle recovery.
Keywords: exercise recovery, NSAID treatment, inflammation, resistance exercise, leucocyte
INTRODUCTION
Unaccustomed resistance exercise often results in tissue damage and inflammation, leading
to delayed onset muscle soreness (DOMS) and a consequent reduction in force production
(Faulkner et al., 1993; Tidball, 1995). Animal models and in vitro studies have identified that local
and systemic inflammation exerts a regulatory influence during the different phases of muscle
recovery, including myofibrillar disruption, cellular necrosis, satellite cell activation, maturation
and subsequent regeneration, and adaptation (Fridén et al., 1981; Armstrong et al., 1991). Thus,
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post-exercise inflammation is intimately necessary and a key
feature of the normal process of tissue regeneration and
adaptation following acute muscle damage. However, excessive
inflammation is considered a potential cause of prolonged
post-exercise muscle soreness and may have a negative effect
on muscle recovery (Armstrong et al., 1991; Smith, 1991);
consequently strategies to reduce or counteract inflammation are
commonly implemented to aid in improving muscle recovery
after exercise (Urso, 2013).
Non-steroidal anti-inflammatory drugs (NSAIDs) are
commonly used as a treatment strategy in exercise and
sports medicine to assist with recovery from exercise-induced
inflammation, particularly following soft-tissue injury. NSAIDs
inhibit the cyclooxygenase (COX-1 and 2) enzymes and
consequently the formation of prostanoids (prostaglandins,
prostacyclins, and thromboxanes) that play a diverse role in
acute inflammation (Markworth et al., 2013). Prostanoids
stimulate an acute inflammatory process by controlling local
blood flow, vascular permeability, leucocyte infiltration, and
triggering sensations of pain (Markworth et al., 2013; Urso,
2013). In animal models of acute muscle damage, treatment
with NSAIDs blunts the infiltration of leucocytes into muscle
tissue (Lapointe et al., 2003; Bondesen et al., 2004) and causes
a reduction in creatine kinase (CK) (Mishra et al., 1995).
Consequently, NSAIDs can also inhibit myofiber regeneration,
satellite cell proliferation and differentiation, and overload-
induced muscle hypertrophy (Mishra et al., 1995; Bondesen
et al., 2004, 2006). These findings provide preliminary evidence
that NSAIDs compromise the physiological link between
processes of acute muscle damage, inflammation and cellular
regeneration.
Research into the effects of NSAIDs on exercise-induced
muscle damage and inflammation has produced equivocal
findings. In exercise models, NSAID administration has been
shown to attenuate post-exercise DOMS in some (Baldwin et al.,
2001; Tokmakidis et al., 2003; Paulsen et al., 2010), but not
all studies (Trappe et al., 2002; Krentz et al., 2008; Mikkelsen
et al., 2009; Hyldahl et al., 2010). While a precise cellular
mechanism for an analgesic effect of NSAIDs remains unclear,
it has been largely ascribed to their effect on prostaglandin
synthesis and the capacity of NSAIDs to interfere with aspects
of inflammatory cell function (Hersh et al., 2000; Peterson
et al., 2003). Previous research has demonstrated that oral
consumption of both ibuprofen, a non-selective NSAID and
acetaminophen, an analgesic also known as paracetamol, had no
effect on macrophage infiltration at 24 h following an eccentric
exercise protocol (Peterson et al., 2003). Similarly treatment with
naproxen, another non-selective NSAID, had no effect on the
infiltration of leucocyte common antigen positive cells following
a unilateral, isotonic resistance exercise protocol (Bourgeois et al.,
1999). Interestingly, Paulsen et al. (2010) suggested a blunting
effect of the COX-2 specific celecoxib following maximum
eccentric muscle contractions (Paulsen et al., 2010). This research
identified a tendency for higher monocyte/macrophage numbers
in subjects within the placebo group, and those subjects who were
identified as “high-responders” to the exercise protocol based on
the number of inflammatory leucocytes (Paulsen et al., 2010).
Although this is not a particularly robust finding, it has led to the
hypothesis that NSAIDs may influence leucocyte infiltration in
skeletal muscle when a sufficiently strong and early inflammatory
reaction is present (Paulsen et al., 2010). This hypothesis would
suggest that the intensity of the exercise stimulus and the
consequent muscle-damage response would be largely influential
in determining the effect of a pharmacologically based anti-
inflammatory intervention.
Conflicting findings also exist with regard to the effect
of NSAIDs on the regenerative capacity of skeletal muscle
following exercise-induced muscle damage. The non-selective
COX inhibitor ibuprofen blunted skeletal muscle protein
synthesis (Trappe et al., 2002) while local intramuscular
infusion of indomethacin (Mikkelsen et al., 2011) and the
oral administration of the COX-2 selective NSAID celecoxib
(Burd et al., 2010; Paulsen et al., 2010) had no such effect.
Similarly, treatment with indomethacin inhibited post-exercise
satellite cell proliferation (Mikkelsen et al., 2009). Recent work
from our group demonstrated that treatment with ibuprofen
inhibited early translational signaling responses involved in post-
exercise muscle hypertrophy (Markworth et al., 2014). A clear
mechanistic pathway for NSAIDs to influence the physiological
link between post-exercise inflammation and skeletal muscle
regeneration remains elusive.
These discrepancies in the research to date are likely due
to differences in the exercise protocol (concentric vs. eccentric
muscle contractions), the training status of subjects, the timing
of muscle biopsies, and the type of NSAID, the dosage
administered, and method of administration. Further research is
required to determine whether NSAID administration affects the
infiltration of leucocyte populations following exercise-induced
muscle damage and how this influences post-exercise adaptive
pathways. The aim of the present study was to investigate if
oral administration of the NSAID ibuprofen influenced skeletal
muscle leucocyte infiltration during the first 24 h after muscle-
damaging resistance exercises. We also aimed to explore how
any changes in leucocyte infiltration were related to markers
of muscle damage, including circulating muscle proteins CK
and myoglobin, and subjective markers of muscle soreness.
We hypothesized that the ingestion of ibuprofen following
acute resistance exercise would not influence the infiltration of
leucocytes, however it would attenuate sensations of DOMS.
MATERIALS AND METHODS
Participants
As described previously, 16 healthy male subjects were recruited
to participate in the study (Table 1; Markworth et al., 2013). It
is important to note that the purpose of the original study by
Markworth et al. (2013) was to profile the human eicosanoid
response to acute exercise in blood plasma samples, as opposed
to the aim of the present study which was to determine the
effect of oral ingestion of ibuprofen on leucocyte recruitment
and infiltration following an acute bout of traditional resistance
exercise.While the subjects and experimental design are the same
in both studies the aims and dependent variables reported are
different. Exclusion criteria included participation in a lower
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TABLE 1 | Subject characteristics and strength testing data.
Characteristics Strength (1 RM)
Age (y) Height (m) Body mass (kg) BMI Squat (kg) Leg press (kg) Leg extension (kg)
PLA 23.9 ± 1.3 1.89 ± 0.1 86.9 ± 4.5 24.5 ± 1.2 94.9 ± 5.4 237 ± 17 236 ± 18
IBU 23 ± 0.5 1.89 ± 0.1 89.1 ± 4.4 24.8 ± 0.8 91.9 ± 6.0 240 ± 15 196 ± 22
Values are mean values ± SEM. No significant differences were observed between the two groups. PLA, placebo; IBU, Ibuprofen; BMI, body mass index.
body resistance exercise program within the last 6 months to
ensure a muscle damage response from the exercise stimulus,
and/or previous chronic treatments with anti-inflammatory
medication. Participants also completed a medical screening to
identify any potential risk factors for them to perform strenuous
physical activity.
Ethics Approval
All procedures involved in this study were approved by
the Deakin University Human Research Ethics Committee
(DUHREC 2010-019) and muscle sampling procedures were
performed in accordance with the Helsinki declaration. Each
participant was provided with written and oral details of the
nature and requirements of the study and provided written
consent to participate.
Familiarization
Each participant completed a familiarization and strength testing
session at least 7 days prior to completing the exercise protocol.
Details of the familiarization session have been described
previously (Markworth et al., 2013). Briefly, subjects performed
repetition maximum testing for the Smith machine-assisted
squat, the leg press and the leg extension to determine their
experimental exercise load [80% of a 1 repetition maximum (1
RM)]. The maximum weight the subject could lift for 5–8 reps
was determined, and these data were entered into the Brzycki
equation to predict 1 RM (Whisenant et al., 2003). Subjects were
asked to abstain from any further activity until the completion of
the trial.
Experimental Procedures
The participants reported to the laboratory on the morning
of the trial in an overnight fasted state. They were asked to
abstain from caffeine, tobacco and alcohol for the 24 h preceding
the trial. Participants rested in a supine position for 30min,
following which the first muscle biopsy sample was taken.
Each participant then completed a 10min warm-up protocol
comprised of 5min of low intensity cycling on a stationary
bike, and one low-intensity set of each exercise at a weight of
each subject’s own choice within the range of 30–50% 1 RM.
The resistance exercise session consisted of three sets of 8–10
repetitions performed on a Smith machine assisted squat, a 45◦
leg press and a leg extension at 80% of a predicted 1 RM. The
exercises were performed as a circuit with 1min rest permitted
between exercises and 3min rest between sets. This protocol
has been used previously and has been a sufficient stimulus to
activate inflammatory signaling pathways (Vella et al., 2012) and
was implemented to replicate a commonly used exercise routine.
After exercise, the subjects rested while subsequentmuscle biopsy
samples were collected. After the 3 h biopsy, participants were
provided a standardized meal and were allowed to go home.
The following morning, participants reported to the laboratory
in an over-night fasted state for a 24 h muscle biopsy and blood
sample.
Standardized Meals
Standardized meals were provided to participants on the night
before the trial, (carbohydrate 57%, fat 22%, protein 21%),
immediately following the 3 h muscle biopsy (carbohydrate 71%,
fat 13%, protein 18%), and in the evening (carbohydrate 64%, fat
27%, protein 18%) on the day of the exercise trial. Participants
were permitted to drinkwater ad libitum andwere asked to report
if they could not finish their allocated meals. This nutrition plan
was included to ensure that each participant received the same
relative percentage of macro- and micro-nutrients.
NSAID Administration
Prior to exercise, participants were randomly assigned in
a double-blind method, to consume either the maximum
recommended dose of ibuprofen (IBU, n = 8) or a placebo
control (gelatin capsules identical in appearance containing
powdered sugar in place of ibuprofen) (PLA, n = 8). The IBU
group consumed three doses of 400mg of ibuprofen throughout
the trial day. The first dose was administered immediately prior
to the first muscle biopsy sample. Participants were instructed
to consume the following two doses at 6 and 12 h following
the exercise protocol. Follow-up phone calls from the research
team ensured compliance. To ensure this dosing structure was
appropriate to maintain biologically active levels of ibuprofen,
ibuprofen concentration was measured in blood serum samples
and these data are reported elsewhere (Markworth et al.,
2013).
Sample Collection
Venous blood samples were drawn prior to exercise, within 5min
post exercise (here-after referred to as 0 h post-exercise), and at 1,
2, 3, and 24 h post-exercise. Blood samples were drawn through
an indwelling catheter into VACUETTE serum tubes (Greiner,
Bio-One, Stonehouse UK). Whole blood was allowed to clot at
room temperature. Samples were then centrifuged at 1000 × g
for 10min. The serum layer was collected and stored at −80◦C
for subsequent analysis.
Muscle biopsy samples were obtained from the vastus
lateralis muscle under local anesthesia (Xylocaine 1%) using
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a percutaneous needle biopsy technique modified to include
suction (Buford et al., 2009). To minimize interference from
the biopsy procedure, samples prior to exercise and at 24 h post
exercise were taken from the same leg, while samples taken at
0 and 3 h post-exercise were taken from the contralateral leg.
Samples obtained within the same leg were taken at least 5 cm
from the previous incision site. We have previously reported
that this technique is effective for minimizing the risk of any
inflammation arising from the biopsy procedure confounding
exercise-induced inflammation (Vella et al., 2012). Tissue-Tek
immersed tissue was rapidly frozen in isopentane cooled liquid
nitrogen before storage at−80◦C.
Immunohistochemistry
Cross sections (8µm) of muscle tissue were cut using a
microtome at −20◦C (CM3050, Leica, Germany) and mounted
on microscope slides (Superfrost Plus, Thermo Scientific,
MA, USA), air-dried and stored at −80◦C. Each subject’s
muscle sections from all time points were mounted on the
same microscope slide. Serial muscle cross-sections were
stained with three different leucocyte antibodies, MPO (#0398,
DakoCytomation, Glostrup, Denmark; dilution 1:2000), CD66b
(#CLB-B13.9, Sanquin Reagents, Amsterdam, The Netherlands;
dilution 1:500), and CD68 (#EBM-11, DakoCytomation,
Glostrup, Denmark; dilution 1:300). Furthermore, the sections
were also stained with dystrophin antibody (ab15277, Abcam,
Cambridge, UK) for visualizing borders of muscle fibers.
Sections were fixed in 4% paraformaldehyde solution in a
staining jar for 5min at room temperature and rinsed twice
for 10min in phosphate buffered saline (PBS) containing 0.5%
Tween 20 (Sigma-Aldrich). The microscope slides were moved
into a humidified chamber and non-specific binding sites were
blocked with 1% bovine serum albumin (BSA) on the section for
45min at room temperature. Sections were incubated overnight
with leucocyte and dystrophin antibodies diluted in 1% BSA
at 4◦C. After overnight incubation, the slides were washed
three times for 10min in PBS-Tween in a staining jar. Slides
were moved back to the humidified chamber and sections
were incubated for 45min with secondary antibodies diluted
1:200 in 1% BSA at room temperature. Alexa Fluor R© 594
F(ab′)2 fragment of goat anti-rabbit and Alexa Fluor R©488 anti-
mouse IgG (Invitrogen, Eugene, Oregon, USA) were used as a
secondary antibodies. The fluorochrome-stained sections were
washed three times for 10min in PBS-Tween. After the last
washing in PBS-Tween, the sections weremounted on ProLong R©
Gold Antifade reagent with DAPI (Invitrogen, Eugene, Orgeon,
USA).
Muscle sections were visualized using a high-resolution
camera (DP72, Olympus, Japan) mounted on a microscope
(BX61, Olympus, Japan) with a fluorescence light source (X-
Cite 120PCQ, EXFO, Canada). The number of MPO, CD66b,
and CD68 positive cells (as well as the total number of muscle
fibers from the area included) was counted. Data was calculated
as percentage of MPO, CD66b, or CD68 positively stained cells
per 100 skeletal muscle fibers. Areas of sections that contained
freeze damage or were folded due to the cutting procedure were
not included in the analysis.
Biochemical Assays
Serum creatine kinase activity in pre- and post-exercise blood
samples was analyzed using an enzymatic assay (CK-NAC
kit, CDT14010, Thermo-Fisher Scientific Clinical Diagnostics,
Sydney, Australia) and an automated clinical analyser (Cobas
Mira, Roche Diagnostics, Germany). Serum myoglobin
concentration was also measured in these samples using an
immunoassay (Roche Diagnostics, Germany) and an automated
clinical analyzer (Cobas E411, Roche Diagnostics, Germany).
The intra-assay coefficient of variation was 10.4% for creatine
kinase and 1.7% for myoglobin.
Muscle Soreness Assessment
Upon arrival at the laboratory and prior to the first muscle
biopsy procedure, as well as 24 h following exercise prior to
the fourth and final muscle biopsy, subjects were asked to rate
their subjective muscle soreness on a 0–10 visual analog scale.
The subjects were instructed to contract, stretch, and palpate
the quadriceps muscle to assess general muscle soreness. In
both instances 0 was considered to represent no pain and
correspondingly a rating of 10 was considered to represent
intense pain.
Statistics
Data are expressed as means ± SEM. Prior to analysis the
data displaying a lack of normality were log transformed to
stabilize variance. Data were analyzed using a two-way ANOVA
with repeated measures for time. The sphericity adjustment
was checked, and if required, a Greenhouse-Geisser epsilon
correction was applied. Where no significant effect for treatment
was observed, we explored pair-wise comparisons between
individual time-points using the Least Significant Difference
(LSD) of means. Bivariate relationships were examined with
a Spearman rank correlation test. These statistical analyses
were performed using GenStat for Windows 16th Edition (VSN
International, Hemel Hempstead, UK). Confidence intervals
were calculated at 90% using a bootstrapping technique for non-
normally distributed data using SPSS Statistics Version 22 (IBM,




Muscle soreness showed a main effect for time (p < 0.01),
suggesting that the exercise protocol was sufficient to induce a
muscle stress response. No effect of ibuprofen treatment was
observed (Figure 1).
Immunohistochemistry
The number of MPO+ cells per 100 myofibers analyzed showed a
main effect for time (P < 0.01). No main effect for treatment
(P = 0.250) or time × treatment (P = 0.709) was observed
(Figure 2A). LSD pairwise comparisons indicated a significant
increase in MPO+ cells at all sampling time points post-exercise.
The greatest increase in MPO+ cells was observed at 3 h post-
exercise (Figure 2B). Similarly, the number of CD66b+ cells per
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FIGURE 1 | Subjective rating for delayed onset muscle soreness
(DOMS) Values depicted are mean values ± SEM. *denotes statistical
significance from pre-exercise values (p < 0.05). White bars, PLA group; black
bars, IBU group. This figure has been adapted from Vella et al. (2014).
100 myofibers showed a main effect for time (P < 0.05), with
no main effect for treatment (P = 0.149) or time × treatment
interaction (P = 0.907; Figure 2C). LSD pairwise comparisons
indicated a significant increase in the number of CD66b+ cells
at 3 h post exercise (Figure 2D). The number of CD68+ cells
per 100 myofibers analyzed showed no effect for time (P =
0.061), treatment (P = 0.530) or time × treatment interaction
(P = 0.688; Figure 2E). MPO+, CD66b+, and CD68+ cells were
observed within the endomysium and the perimysium, with no
cellular infiltration occurring at any time point. Representative
images for each cell surface marker are presented in Figure 3.
Serum Proteins
Serum CK activity demonstrated a main effect for time (P <
0.01) with no effect for treatment (P = 0.843) or time ×
treatment interaction (P = 0.494; Figure 4A). LSD comparisons
revealed that serum CK increased from pre-exercise values at
2 h post-exercise and peaked at 24 h post-exercise (Figure 4B).
Similarly, serum myoglobin concentration showed a main effect
for time (P < 0.01) with no effect for treatment (P =
0.710) or time × treatment interaction (P = 0.666; Figure 4C).
LSD comparisons demonstrated that the biggest increase in
serum myoglobin concentrations occurred at 1 h post-exercise
and remained significantly elevated up to 3 h post exercise
(Figure 4D).
Correlation Analysis
In general, large inter-individual differences were seen in the
appearance of all of the leucocyte cell types. Results from the
Spearman rank correlation test showed no correlation between
the histochemical appearance of inflammatory leucocytes,
biological markers of muscle damage, and subjective markers
of muscle soreness (Table 2). Anecdotally, three subjects were
identified as the highest responders in the appearance of cell
surface markers applicable for localization of neutrophils (one
subject within the placebo group, and two subjects within the
ibuprofen group). However, these subjects showed no significant
increase in CK, myoglobin or subjective markers of muscle
damage when compared with the other subjects. Interestingly,
subject 5 recorded the highest number of CD66b+ cells and
MPO+ cells, whereas he presented with the lowest subjective
rating for DOMS.
DISCUSSION
Themain finding of this study was that ibuprofen, a non-selective
COX inhibitor, had no effect on the histological detection of
leukocytes following an acute bout of traditional resistance
exercise. Serum CK and myoglobin, and muscle soreness
also did not change in response to ibuprofen. Furthermore,
no correlation was observed between the accumulation of
inflammatory leucocytes, increases in CK or myoglobin, and
sensations of DOMS. These observations suggest that the
intramuscular infiltration of inflammatory white blood cells, or
an increase in serum levels of intramuscular proteins, are not
predictive of post-exercise muscle soreness.
The current study focused on the acute local inflammatory
response to exercise-induced muscle damage. Our protocol was
effective in inducing muscle soreness as shown in Figure 1. It is
important to note that we have previously reported this exercise-
induced stress response (Vella et al., 2014). However, we felt it
was necessary to re-emphasize this response here. In the present
study we identified an increase in the histological appearance
of CD66b+ and MPO+ cells that peaked at 3 h post exercise
and found no effect of NSAID treatment. CD66b is a highly
specific cell surface marker for detecting human neutrophils, and
this is the first paper to show a small but significant increase
in the intramuscular number of CD66b+ cells following acute
resistance exercise. Paulsen et al. (2013) were unable to identify
any change in the number of CD66b+ cells in the elbow flexors
at 1, 2, 4, or 7 days following 70 maximal eccentric contractions
(Paulsen et al., 2013). Differences in the timing of muscle biopsy
samples may explain the discrepancy between the two trials, and
suggest that neutrophils may be involved in the acute phase
inflammatory response to resistance exercise. We also identified
a small but significant increase in the number of MPO+ cells
at all sampled time points, with a peak in expression at 3 h
post exercise. MPO has typically been used to detect changes
in neutrophils, and an increased number of MPO+ cells have
been reported following high-force eccentric muscle contractions
(Mahoney et al., 2008; MacNeil et al., 2011). However, MPO
is also expressed on the lysosomes of monocytes and has been
detected on basophils and eosinophils, perhaps providing a
reason why there were a higher number of MPO+ cells when
compared to CD66b+ cells detected in the present study (Paulsen
et al., 2013).
No change was identified in the number of CD68+ cells. CD68
cell counts are widely used as a marker of monocyte/macrophage
infiltration. However, CD68 may also be expressed on other cell
types including satellite cells and fibroblasts (Paulsen et al., 2013).
Other researchers have been able to identify a change in CD68+
cells following exercise-induced muscle damage (Peterson et al.,
2003; Mahoney et al., 2008; MacNeil et al., 2011). Each of
these studies have used a high-force maximal eccentric muscle
contraction protocol, which may suggest that the detection of
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FIGURE 2 | Immunohistochemistry data for muscle cells staining positive for myeloperoxidase (MPO), showing group specific data (A) and collapsed
data (B), CD66b showing group specific data (C), and collapsed data (D), and CD68 showing group data only (E). Data represent the mean number of
positively stained cells per 100 fibers analyzed ± SEM. **denotes statistical significance from pre-exercise values (p < 0.01). *denotes statistical significance from
pre-exercise values (p < 0.05). ∧denotes statistical significance from 0h post-exercise (p < 0.05). White bars, PLA group; black bars, IBU group.
CD68+ cells is dependent on the extent of skeletal muscle
damage.
Previous research exploring the effect on NSAIDs on
post-exercise inflammation has produced equivocal findings.
Earlier research from in-vivo rodent trials demonstrated a
blunted inflammatory response to eccentric muscle contractions
following the administration of both selective and non-selective
NSAIDs (Lapointe et al., 2002a,b; Bondesen et al., 2004, 2006).
However, these findings are yet to be supported in human
trials (Bourgeois et al., 1999; Peterson et al., 2003; Tokmakidis
et al., 2003). Peterson et al. (2003) found no effect of oral
ibuprofen administration on the appearance of CD68+ cells 24 h
following 100 eccentric muscle contractions (Peterson et al.,
2003). Similarly, Tokmakidis showed no effect of ibuprofen
on circulating white blood cells 24 h following an eccentric
exercise protocol (Tokmakidis et al., 2003). Paulsen et al. (2010)
proposed the concept of an inflammatory threshold, suggesting
that NSAIDs may only influence post-exercise inflammation in
response to a sufficiently strong inflammatory stimulus (Paulsen
et al., 2010). It was suggested that the absence of an intramuscular
prostaglandin response to exercise, specifically PGE2, could
explain the lack of an NSAID effect on leucocyte recruitment
(Trappe et al., 2001; Paulsen et al., 2010). Interestingly, our
group recently reported an increase in serum PGE2 in samples
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that were obtained during the same exercise trials as those
currently reported (Markworth et al., 2013). This change in
serum PGE2 was blunted by the administration of ibuprofen
FIGURE 3 | Immunohistochemical analysis of skeletal muscle samples
following about of resistance exercise. Sections were probed with
antibodies raised against leucocyte cell surface markers (green; A—MPO,
B—CD66b, C—CD68) and dystrophin (red), while DAPI was used to stain
nuclei (blue). Scale bars = 50µm.
and suggests that in the presence of a blunted prostaglandin
response to exercise, NSAID treatment had no effect on leucocyte
recruitment within skeletal muscle. Although this finding does
not refute the possibility of an inflammatory threshold, based
on our previous findings (Markworth et al., 2013), it is
reasonable to suggest that the presence of an exercise-induced
serum prostaglandin response is not the required underlying
mechanism for neutrophil infiltration of muscle during the early
hours of post-exercise recovery.
In accordance with previous studies, resistance exercise
resulted in an increase in serum CK and myoglobin, and
subjective muscle soreness (Nosaka et al., 2006). Although large
inter-individual variations in the human response to exercise
can make it difficult to establish causal relationships, there
was no relationship between the appearance of leucocytes
and blood-derived markers of muscle damage or sensations
of muscle soreness. Interestingly, the subject with the highest
number of CD66b+ and MPO+ cells presented with the lowest
subjective rating of DOMS. These findings provide support for
the assumption that leucocyte recruitment and inflammation do
not consistently cause DOMS.
From animal studies it appears that cellular events in post-
exercise inflammation, occur concomitantly with the onset of
DOMS (Armstrong et al., 1991; Faulkner et al., 1993). The
mechanistic link has been proposed to be a leucocyte-mediated
FIGURE 4 | Blood derived proteins creatine kinase (A,B) and myoglobin (C,D). Values depicted are mean values ± SEM. (A,C) represent data divided into two
treatment groups; (B,D) represent collapsed data. *denotes statistical significance from pre-exercise values (p < 0.05). **denotes statistical significance from
pre-exercise values (p < 0.01). ∧denotes statistical significance from 1, 2, and 3 h post exercise (p < 0.05). White bars, PLA; black bars, IBU.
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TABLE 2 | Spearman rank correlation analysis.
CK MYO CD68+ CD66b+ MPO+ DOMS
CK – 0.59 (−0.01 − 0.91) −0.46 (−0.88 − 0.8) 0.15 (−0.42 − 0.61) 0.36 (−0.14 − 0.73) 0.01 (−0.60 − 0.62)
MYO – – 0.01 (−0.55 − 0.52) 0.14 (−0.42 − 0.69) 0.35 (−0.21 − 0.67) −0.33 (−0.74 − 0.24)
CD68+ – – – 0.05 (−0.46 − 0.56) −0.27 (−0.75 − 0.33) −0.37 (−0.82 − 0.25)
CD66b+ – – – – 0.41 (−0.13 − 0.84) −0.37 (−0.78 − 0.16)
MPO+ – – – – – 0.08 (−0.49 − 0.56)
DOMS – – – – – –
Values depicted are the correlation coefficient with 90% confidence intervals in parenthesis. Statistical significance was set at p < 0.05. No statistically significant correlations were
observed. CK, creatine kinase; MYO, myoglobin; MPO, Myeloperoxidase; DOMS, delayed-onset muscle soreness.
release of cytotoxic substances and reactive oxygen species
as a bi-product of phagocytosis (Connolly et al., 2003).
Furthermore, the prostaglandin response to exercise has been
shown to occur concurrently to the onset of DOMS, and
is known to influence both the recruitment of inflammatory
leucocytes and neural afferents to pain (Markworth et al., 2013).
However, in line with the current findings, the accumulation
of inflammatory leucocytes in human skeletal muscle tissue
during exercise recovery appears to be both spatially and
temporally out of phase with the development of DOMS
(Paulsen et al., 2010). Malm et al. (2004) explored the
concept that the activation of local leucocytes present in the
epimysium may be involved in the regulation of DOMS.
This hypothesis has since received support from both rodent
(Gibson et al., 2009) and human trials (Crameri et al., 2007;
Raastad et al., 2010) and presents a promising area for future
research.
CONCLUSION
This is the first study to demonstrate that ibuprofen
administration has no effect on the histological appearance
of inflammatory white blood cells following an acute bout
of traditional resistance exercise. We also found no effect
of ibuprofen administration on blood markers of muscle
damage or subjective muscle soreness, and no significant
correlations between leucocyte numbers and post-exercise
muscle damage or soreness. Future research needs to explore
the possibility of an inflammatory threshold above which
NSAID administration influences post-exercise inflammation.
The underlying cause of post-exercise muscle soreness also
remains largely unknown. Future investigations are needed to
determine the role that inflammation plays in exercise-induced
DOMS.
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